Clinical trials without humans – why computer simulations could make drugs a lot cheaper
The downside to clinical trials is that they are complex, take years to complete and are extremely expensive. However, a recent development called “in silico clinical trials” (trials conducted using computer simulation) are beginning to show their potential for substantially speeding up trials and drastically reducing their costs. And drugs regulators are starting to pay attention.
Indeed, evidence from an in silico clinical trial has already been used to get approval for a new type of pacemaker.
Clinical trials without humans – why computer simulations could make drugs a lot cheaper (theconversation.com)